Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Reza Elahi
Observed names:
Elahi R,
R. Elahi
Institution:
Zanjan University of Medical Sciences
Observed institutions:
Zanjan University of Medical Sciences,
University of Pittsburgh Medical Center,
Tehran University of Medical Sciences
ORCID:
0000-0001-9612-2587
Observed ORCID:
0000-0001-9612-2587
OpenAlex ID:
A5010170200
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Simon I Hay
, Kanyin Liane Ong
, et al.
·
The Lancet
·
1,234
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2025
·
Mohsen Naghavi
, Hmwe Hmwe Kyu
, et al.
·
The Lancet
·
813
PDF
Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
2025
·
Austin E Schumacher
, Peng Zheng
, et al.
·
The Lancet
·
275
Solid Tumors Challenges and New Insights of CAR T Cell Engineering
2019
·
Safa Tahmasebi
, Reza Elahi
, et al.
·
Stem Cell Reviews and Reports
·
115
Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects
2021
·
Reza Elahi
, Amir Hossein Heidary
, et al.
·
Stem Cell Reviews and Reports
·
96
PDF
Immunobiology and immunotherapy of COVID‐19: A clinically updated overview
2020
·
Abdolreza Esmaeilzadeh
, Reza Elahi
·
Journal of Cellular Physiology
·
95
PDF
Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells
2018
·
Reza Elahi
, Elnaz Khosh
, et al.
·
Frontiers in Immunology
·
83
PDF
Programmable and multi-targeted CARs: a new breakthrough in cancer CAR-T cell therapy
2020
·
S. Tahmasebi
, R. Elahi
, et al.
·
Clinical & Translational Oncology
·
63
An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)
2022
·
Reza Elahi
, Parsa Karami
, et al.
·
International Immunopharmacology
·
54
PDF
Therapeutic Properties of M2 Macrophages in Chronic Wounds: An Innovative Area of Biomaterial-Assisted M2 Macrophage Targeted Therapy
2024
·
Mahdis Nazari
, Siavash Taremi
, et al.
·
Stem Cell Reviews and Reports
·
53
OMICRON: Virology, immunopathogenesis, and laboratory diagnosis
2022
·
Mahsa Bazargan
, Reza Elahi
, et al.
·
The Journal of Gene Medicine
·
53
IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches
2024
·
Reza Elahi
, Mahdis Nazari
, et al.
·
Molecular Immunology
·
48
PDF
Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches
2023
·
Vahid Mohammadi
, Armin Jahani Maleki
, et al.
·
Stem Cell Reviews and Reports
·
40
The gut microbiota and cardiovascular disease: Exploring the role of microbial dysbiosis and metabolites in pathogenesis and therapeutics
2025
·
Amin Mohsenzadeh
, Sahar Pourasgar
, et al.
·
Life Sciences
·
34
IL-38 as an early predictor of the ischemic stroke prognosis
2021
·
Maryam Zare Rafie
, Abdolreza Esmaeilzadeh
, et al.
·
Cytokine
·
32
An updated overview of radiomics-based artificial intelligence (AI) methods in breast cancer screening and diagnosis
2024
·
Reza Elahi
, Mahdis Nazari
·
Radiological Physics and Technology
·
28
PDF
Endocrine and metabolic complications of COVID-19: lessons learned and future prospects
2022
·
Abdolreza Esmaeilzadeh
, Reza Elahi
, et al.
·
Journal of Molecular Endocrinology
·
28
PDF
Immune-Based Therapy for COVID-19
2021
·
Abdolreza Esmaeilzadeh
, Davood Jafari
, et al.
·
Advances in experimental medicine and biology
·
26
Transforming growth factor β (TGF-β) pathway in the immunopathogenesis of multiple sclerosis (MS); molecular approaches
2023
·
Abdolreza Esmaeilzadeh
, Vahid Mohammadi
, et al.
·
Molecular Biology Reports
·
25
PDF
CAR-T cell therapy in hepatocellular carcinoma: from mechanistic insights to clinical translation
2025
·
Reza Elahi
, Yassine Alami Idrissi
, et al.
·
Cancer Treatment Reviews
·
17
PDF
Advanced MRI Methods for Diagnosis and Monitoring of Multiple Sclerosis ( MS )
2025
·
Reza Elahi
, Siavash Taremi
, et al.
·
Journal of Magnetic Resonance Imaging
·
17
Current progress of chimeric antigen receptor (CAR) T versus CAR NK cell for immunotherapy of solid tumors
2023
·
Abdolreza Esmaeilzadeh
, Kaveh Hadiloo
, et al.
·
Life Sciences
·
17
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks
2022
·
Abdolreza Esmaeilzadeh
, Armin Jahani Maleki
, et al.
·
Expert Review of Vaccines
·
17
The role of heat shock proteins (HSPs) in type 2 diabetes mellitus pathophysiology
2023
·
Abdolreza Esmaeilzadeh
, Vahid Mohammadi
, et al.
·
Journal of Diabetes and its Complications
·
16
Targeting the cGAS-STING pathway as an inflammatory crossroad in coronavirus disease 2019 (COVID-19)
2023
·
Reza Elahi
, Salar Hozhabri
, et al.
·
Immunopharmacology and Immunotoxicology
·
15
Show more works
View as search
Works count:
40
Citation count:
3,121
H-index:
19
I10-index:
26
Year
Topic
Type